These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Grey matter abnormalities in methcathinone abusers with a Parkinsonian syndrome. Juurmaa J; Menke RA; Vila P; Müürsepp A; Tomberg T; Ilves P; Nigul M; Johansen-Berg H; Donaghy M; Stagg CJ; Stepens A; Taba P Brain Behav; 2016 Nov; 6(11):e00539. PubMed ID: 27843694 [TBL] [Abstract][Full Text] [Related]
5. Unusual magnetic resonance imaging of the head in manganese and ephedrone intoxication - a case report. Jastrzębski K; Gałecki P; Sanchez SI Pol Merkur Lekarski; 2021 Dec; 49(294):434-436. PubMed ID: 34919088 [TBL] [Abstract][Full Text] [Related]
6. A Parkinsonian syndrome in methcathinone users and the role of manganese. Stepens A; Logina I; Liguts V; Aldins P; Eksteina I; Platkājis A; Mārtinsone I; Tērauds E; Rozentāle B; Donaghy M N Engl J Med; 2008 Mar; 358(10):1009-17. PubMed ID: 18322282 [TBL] [Abstract][Full Text] [Related]
7. Manganese Encephalopathy among Ephedron Abusers. Janocha-Litwin J; Marianska K; Serafinska S; Simon K J Neuroimaging; 2015; 25(5):832-5. PubMed ID: 25255816 [TBL] [Abstract][Full Text] [Related]
8. Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure. Sikk K; Taba P; Haldre S; Bergquist J; Nyholm D; Askmark H; Danfors T; Sörensen J; Thurfjell L; Raininko R; Eriksson R; Flink R; Färnstrand C; Aquilonius SM Acta Neurol Scand; 2010 Apr; 121(4):237-43. PubMed ID: 20028341 [TBL] [Abstract][Full Text] [Related]
9. [Encephalopathy caused by intravenous potassium permanganate used for illegal production of methcathinone (ephedrone) from medicines containing pseudoephedrine]. Habrat B; Baran-Furga H; Sienkiewicz-Jarosz H; Sein Anand J; Poniatowska R Przegl Lek; 2013; 70(8):613-6. PubMed ID: 24466704 [TBL] [Abstract][Full Text] [Related]
10. Methcathinone "Kitchen Chemistry" and Permanent Neurological Damage. Sikk K; Taba P Int Rev Neurobiol; 2015; 120():257-71. PubMed ID: 26070761 [TBL] [Abstract][Full Text] [Related]
11. A distinct variant of mixed dysarthria reflects parkinsonism and dystonia due to ephedrone abuse. Rusz J; Megrelishvili M; Bonnet C; Okujava M; Brožová H; Khatiashvili I; Sekhniashvili M; Janelidze M; Tolosa E; Růžička E J Neural Transm (Vienna); 2014 Jun; 121(6):655-64. PubMed ID: 24445755 [TBL] [Abstract][Full Text] [Related]
12. Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse. Selikhova M; Tripoliti E; Fedoryshyn L; Matvienko Y; Stanetska H; Boychuk M; Komnatska I; Lees AJ; Sanotsky Y Clin Neurol Neurosurg; 2016 Aug; 147():71-7. PubMed ID: 27310289 [TBL] [Abstract][Full Text] [Related]
13. Manganese toxicity with ephedrone abuse manifesting as parkinsonism: a case report. Iqbal M; Monaghan T; Redmond J J Med Case Rep; 2012 Feb; 6():52. PubMed ID: 22313512 [TBL] [Abstract][Full Text] [Related]